Novelos Therapeutics and Lee's Pharmaceutical Sign Exclusive Collaboration Agreement in China for Cancer and Hepatitis Compounds
20-Dec-2007 -
Novelos Therapeutics, Inc. announced that Novelos signed an exclusive license agreement with Lee's Pharmaceutical (HK) Ltd (which is 30% owned by Sigma-Tau Group through Defiante Farmaceutica Lda) to develop and commercialize in China, including Hong Kong and Macau, as well as in Taiwan, two of ...
license agreements
lung cancer
Macau
+1